Plain-English translation of NCT06856447 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Colorectal Cancer research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing whether , a natural supplement, can help prevent a common side effect of chemotherapy called peripheral neuropathy โ which causes numbness, tingling, and pain in the hands and feet. Half of participants will receive standard chemotherapy alone, while the other half will also take 100 mg of every day. Researchers believe this medication may protect nerves from damage caused by the chemotherapy drugs.
is an effective chemotherapy drug for colorectal cancer, but it frequently damages nerves in the hands and feet, causing pain and numbness that can be severe enough to make patients stop treatment. This medication is being tested because laboratory studies suggest it has antioxidant and anti-inflammatory properties that might protect nerves from this kind of damage.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will receive 12 cycles of standard colorectal cancer chemotherapy (modified FOLFOX-6) given every two weeks, along with medications to prevent nausea and stomach irritation. If you are in the supplement group, you will also take 100 mg of by mouth once each morning, starting after your first chemotherapy cycle and continuing through your 12th cycle. Throughout the study, your doctors will monitor you for nerve damage and other side effects.
AI-generated summary from trial data ยท Jun 28, 2026 ยท Not medical advice
Egypt